“Alex Zhavoronkov, Founder and CEO of generative-AI drug discovery firm Insilico Medicine, discusses the company's plans after it raised $293 million in its initial public offering in Hong…”
2025-12-30
2 quotes
“He talks about using artificial intelligence in early-stage drug discovery, longevity therapeutics, and how Insilico's AI model can simulate different life stages.”